Total Payments
$15,360
2024 Payments
$1,945
Companies
53
Transactions
1,035
Medicare Patients
4,830
Medicare Billing
$461,130
Payment Breakdown by Category
Food & Beverage$13,971 (91.0%)
Other$850.00 (5.5%)
Education$538.89 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,971 | 1,026 | 91.0% |
| Honoraria | $850.00 | 2 | 5.5% |
| Education | $538.89 | 7 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LEO Pharma Inc. | $1,513 | 135 | $0 (2024) |
| MAYNE PHARMA INC. | $1,388 | 129 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,151 | 83 | $0 (2024) |
| Janssen Biotech, Inc. | $1,120 | 54 | $0 (2024) |
| GENZYME CORPORATION | $982.92 | 55 | $0 (2024) |
| ABBVIE INC. | $922.16 | 68 | $0 (2024) |
| Galderma Laboratories, L.P. | $886.19 | 68 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $698.44 | 60 | $0 (2024) |
| Encore Dermatology Inc. | $671.70 | 7 | $0 (2019) |
| UCB, Inc. | $603.61 | 55 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,945 | 118 | Janssen Biotech, Inc. ($231.96) |
| 2023 | $1,244 | 86 | Sun Pharmaceutical Industries Inc. ($166.43) |
| 2022 | $1,592 | 89 | GENZYME CORPORATION ($346.78) |
| 2021 | $1,948 | 151 | SUN PHARMACEUTICAL INDUSTRIES INC. ($353.15) |
| 2020 | $1,697 | 131 | Sun Pharmaceutical Industries Inc. ($231.39) |
| 2019 | $2,023 | 150 | Mayne Pharma Inc. ($383.65) |
| 2018 | $2,610 | 175 | Mayne Pharma Inc. ($717.30) |
| 2017 | $2,299 | 135 | LEO Pharma Inc. ($413.71) |
All Payment Transactions
1,035 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Sensus Healthcare, Inc. | — | Food and Beverage | Cash or cash equivalent | $39.52 | General |
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/27/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.64 | General |
| 11/27/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $0.96 | General |
| 11/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Immunology | ||||||
| 11/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Immunology | ||||||
| 11/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: Immunology | ||||||
| 11/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: DERMATOLOGY | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.73 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Immunology | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.33 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Immunology | ||||||
| 10/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: Immunology | ||||||
| 10/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $0.21 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,254 | 2,102 | $486,766 | $131,147 |
| 2022 | 16 | 1,104 | 1,749 | $412,717 | $105,813 |
| 2021 | 18 | 1,410 | 1,990 | $495,034 | $141,950 |
| 2020 | 16 | 1,062 | 1,477 | $341,927 | $82,220 |
Total Patients
4,830
Total Services
7,318
Medicare Billing
$461,130
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 299 | 446 | $109,716 | $32,388 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 161 | 211 | $76,171 | $21,459 | 28.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 120 | 143 | $42,900 | $12,367 | 28.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 177 | 239 | $54,970 | $11,834 | 21.5% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 11 | 104 | $26,520 | $11,565 | 43.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 29 | 34 | $35,700 | $8,959 | 25.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 55 | 57 | $17,100 | $6,286 | 36.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 62 | 62 | $22,568 | $5,595 | 24.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 40 | 45 | $17,415 | $4,393 | 25.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 49 | 72 | $21,600 | $3,311 | 15.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 118 | 539 | $10,780 | $3,252 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $12,604 | $2,761 | 21.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 22 | $18,832 | $2,335 | 12.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 13 | $6,734 | $1,958 | 29.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 24 | 29 | $5,568 | $998.33 | 17.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 21 | $3,108 | $954.75 | 30.7% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 11 | 13 | $3,900 | $705.49 | 18.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 24 | 29 | $580.00 | $24.17 | 4.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 267 | 397 | $97,089 | $27,650 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 159 | 223 | $80,287 | $21,537 | 26.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 122 | 142 | $42,600 | $12,680 | 29.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 145 | 203 | $46,690 | $9,634 | 20.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 33 | 34 | $35,700 | $8,883 | 24.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 45 | 48 | $14,400 | $5,417 | 37.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 64 | 64 | $23,296 | $5,283 | 22.7% |
About Dr. Smita Agarwal, MD
Dr. Smita Agarwal, MD is a Dermatology healthcare provider based in Bridgewater, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982675633.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Smita Agarwal, MD has received a total of $15,360 in payments from pharmaceutical and medical device companies, with $1,945 received in 2024. These payments were reported across 1,035 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($13,971).
As a Medicare-enrolled provider, Agarwal has provided services to 4,830 Medicare beneficiaries, totaling 7,318 services with total Medicare billing of $461,130. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Bridgewater, NJ
- Active Since 01/31/2006
- Last Updated 12/20/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982675633
Products in Payments
- DUPIXENT (Biological) $1,544
- DORYX (Drug) $1,310
- TREMFYA (Drug) $767.97
- Impoyz (Drug) $671.70
- ENSTILAR (Drug) $633.42
- Cimzia (Drug) $454.31
- ADBRY (Biological) $427.56
- AMELUZ (Drug) $399.57
- SKYRIZI (Biological) $379.37
- DUOBRII (Drug) $363.23
- PICATO (Drug) $359.08
- EUCRISA (Drug) $354.76
- OPZELURA (Drug) $337.41
- RINVOQ (Biological) $309.17
- ILUMYA (Biological) $298.72
- COSENTYX (Biological) $268.93
- Xolegel (Drug) $250.92
- Tremfya (Drug) $246.01
- Otezla (Drug) $240.25
- AMZEEQ (Drug) $221.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.